page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
page 80
page 81
page 82
page 83
page 84
page 85
page 86
page 87
page 88
page 89
page 90
page 91
page 92
page 93
page 94
page 95
page 96
page 97
page 98
page 99
page 100
page 101
page 102
page 103
page 104
page 105
page 106
page 107
page 108
page 109
page 110
page 111
page 112
page 113
page 114
page 115
page 116
page 117
page 118
page 119
page 120
page 121
page 122
page 123
page 124
page 125
page 126
page 127
page 128
page 129
page 130
page 131
page 132
page 133
page 134
page 135
page 136
page 137
page 138
page 139
page 140
page 141
page 142
page 143
page 144
page 145
page 146
page 147
page 148
page 149
page 150
page 151
page 152
page 153
page 154
page 155
page 156
page 157
page 158
page 159
page 160
page 161
page 162
page 163
page 164
page 165
page 166
page 167
page 168
page 169
page 170
page 171
page 172
page 173
page 174
page 175
page 176
page 177
page 178
page 179
page 180
page 181
page 182
page 183
page 184
page 185
page 186

92INNOVATION UKINNOVATION The UK is playing a pivotal role in the evolution of the life- sciences, helping it to attract increasing levels of inward investment Life- science leader As a leader in the world scientific community, and a proven incubator for young and dynamic business tal-ent, the UK is at the forefront of the fast- growing life-sciences sector. Home to the National Health Service ( NHS), the largest publicly funded healthcare system in the world ( spending over £ 90bn a year), the UK is a recognised global hub for life- sciences creativity and delivery, enabling businesses to drive innovation right through to market success. Tomorrow Options Portuguese medical devices company Tomorrow Options recently set up a subsidiary in the UK after receiving assistance from UK Trade & Investment ( UKTI). The firm, which has devised a unique way to detect foot ulcers in diabetes patients, approached UKTI for advice after deciding that the UK was a key target market. " There is a clear need for our product in the UK, which has the highest incidence of diabetes in Europe," explains Paulo Ferreira dos Santos, Co- Founder of Tomorrow Options. " We also knew that the NHS is interested in new technologies that can help with patient care without costing a fortune." After joining UKTI's Soft Landing Zone programme, with a view to exploring opportunities in the UK, Tomorrow Options was introduced to a pilot of an ini-tiative being trialled in Yorkshire. Three months later, the company decided to open a UK subsidiary, based at the University of Sheffield. " The support we have received in the UK has been amazing," enthuses dos Santos, " surpassing all our expectations." www. tomorrow- options. com UK life- sciences organisations and laboratories are pio-neers in exciting new fields such as stem- cell research, aided by the UK's progressive regulatory regime in such areas. These and other cutting- edge developments are helping to deliver new treatments for long- standing ail-ments, such as diabetes, asthma and obesity. Life- Sciences UKTI

UKINNOVATION UK93 UK Trade & Investment As the UK government's inward investment agency, it's our responsibility to understand the UK's strengths and to encourage investment wherever opportuni-ties exist. This means that we can help your company research emerging opportunities and get a new opera-tion up and running as quickly as possible. Our services include: » Impartial advice on where and how to set up business in the UK » In- depth tailored information, including advice on R& D, tax, human capital and visas » Introductions to professional advisers and key contacts » Access to lists of professional service organisations that can support your move to the UK » Access to life- science specialists who have a strong background in the sector » Practical help, including visits to suitable locations, finding business partners and accessing financial incentives » Investment aftercare » Access to UK government to voice views on business regulation and policy. Take advantage of these services and you too could be part of the UK life- sciences success story. For more information, visit: www. uktradeinvest. gov. uk UK life- sciences companies are pioneers in future growth areas such as regenerative and stratified medicine, which will help meet future challenges such as an ageing popu-lation and obesity, and help cancer treatments be more effective. The UK is home to both multinational pharmaceutical giants and to small innovative life- science companies. Five of the world's best- selling pharmaceuticals were developed in the UK, the UK medical biotechnology sec-tor leads Europe in the number of drugs in all stages of clinical development, and more than one third of Europe's bio- pharmaceutical clinical trials take place in the UK's various advanced research facilities. The UK's medical technology sector is also growing rap-idly, with the largest share in Europe at just over 2,000 companies, the majority of which are SMEs. A major con-tributor to the UK's success in life- sciences is the strength of its skills base. According to OECD statistics, the UK, which has four of the world's top 10 universities, has the highest number of life sciences degree- level graduates annually in Europe. Life- Sciences UKTI